You track your HRV. You dose your NMN. You read the Sinclair papers. But published enzymatic data reveals why your NAD+ levels have plateaued: a glycoprotein called CD38 is consuming most of what your supplements produce.
This is not casual supplementation. NMN, the salvage pathway, CD38 glycoprotein activity. You know the enzymatic landscape. The Huberman episodes, the Attia deep dives, the Sinclair papers. You built your stack on primary sources. You have heard Attia explain why mitochondrial dysfunction is upstream of every chronic disease marker.
So you built a stack. NMN for NAD+ production. A resveratrol bottle for antioxidant support. Maybe a separate polyphenol blend. A shelf full of bottles, each targeting one mechanism, each from a different brand, each with its own dosing schedule.
Your HRV has not moved in six months. Your morning resting heart rate has flatlined. Your Oura readiness scores look the same as they did before you started spending $280 a month on longevity supplements.
Here is why.
CD38 is a transmembrane glycoprotein with NADase activity. Its expression increases with age and chronic inflammation. Published peer-reviewed research has established CD38 as the primary driver of age-related NAD+ decline, responsible for degrading the majority of cellular NAD+ stores.
This is not a fringe finding. The mechanism is well-documented in the literature.
Your 500mg NMN capsule enters the salvage pathway. Your body converts it to NAD+. CD38 immediately begins consuming it. The higher your inflammatory load, the more CD38 you express, and the faster the degradation.
Run the math on your own protocol: you are paying for NAD+ production while an enzyme you are not addressing destroys most of the output. It is the equivalent of running your car engine while the oil drain plug is missing. More fuel does not fix a structural leak.
This is why doubling your NMN dose from 250mg to 500mg to 1,000mg produces diminishing returns on your wearable data. You are not under-producing NAD+. You are under-protecting it.
Here is what the standard biohacker longevity protocol looks like in practice:
500mg, $45/month. Addresses NAD+ production only. No CD38 protection.
Total: $122/month at mid-market prices, and well past that on premium brands. One mechanism addressed per product. CD38 protection completely missing. Several capsules every morning, from bottles that were never formulated to work together.
And the NAD+ pathway you are paying $45/month for? It is running at a fraction of capacity because CD38 is consuming the output.
You know the phrase in engineering: optimizing the wrong variable. That is what an NMN-only NAD+ strategy is. You are optimizing production while ignoring degradation.
You understand the CD38 problem. Here is the protocol designed around it.
See the NAD+ and Polyphenol Protocol Breakdown →Cellular aging is not solved by dosing NMN in isolation. Two mechanisms drive the outcome: how much NAD+ you produce and protect, and how much oxidative, polyphenol-mediated cellular stress you counter at the same time. Targeting one while ignoring the other is like measuring VO2max while never training grip strength. You get data on one variable. You miss the system.
9mg carries the fat-soluble polyphenol fraction for absorption.| Your Current Stack ($122/mo) | CLADE™ Longevity Complex ($65-79/mo) | |
|---|---|---|
| NAD+ Production | NMN 500mg ($45/mo) | NMN 255 mg + Trigonelline 60 mg (salvage + Preiss-Handler) |
| NAD+ Protection (CD38) | Not addressed | Testosurge® 150 mg (apigenin CD38 inhibitor) |
| Polyphenol Antioxidant Support | Separate bottle, unpriced above | Resveratrol 300mg + Vinomerix Optima® 210mg (510mg combined) |
| Absorption Base | Not addressed | Wheat Germ Oil 9mg (fat-soluble carrier) |
| Foundation Cofactors | Separate bottles ($32/mo) | Zn, Mg, Methyl Folate, B12 (100% RDI each) |
| Mechanisms Covered | 1 of 2 | 2 of 2 |
| Daily Capsules | Multiple, across separate bottles | 3 |
| Monthly Cost (Subscribe) | $122 | $65 (90-day) / $79 (30-day) |
You have seen the pathway map and the cost comparison. Here is how to evaluate it for your stack.
Plug the Leak. Check Protocol Pricing.The biohacker community runs on data. Subjective reports are interesting. Wearable trends over 90 days are actionable.
Here is what verified users tracking HRV, resting heart rate, and sleep architecture report after switching from multi-bottle stacks to the NAD+ and polyphenol protocol:
These are user-reported outcomes. Individual results vary. The point is not that every user sees identical numbers. The point is that addressing NAD+ production, NAD+ protection, and polyphenol antioxidant support simultaneously produces compound effects that single-mechanism supplementation misses.
You are a data person. So here are the numbers that would make a less honest company uncomfortable:
NMN dose is 255 mg, not 500mg. Standalone NMN products dose at 250-1,000mg because that is their only active. In a protocol where CD38 is actively inhibited, the relevant metric is not how much NMN you ingest but how much NAD+ survives to reach your cells. Published research on CD38's role in NAD+ degradation supports the logic: protect what you produce rather than overproduce into an unprotected system.
CLADETM does not contain Urolithin A, and does not compete on mitophagy. Timeline's Mitopure is a single-mechanism product priced at $125/month built around Urolithin A. That is not the mechanism this formula is built on. CLADETM Longevity Complex is built on NAD+ support (NMN plus Trigonelline plus a CD38-inhibiting apigenin extract) and polyphenol antioxidant support (Resveratrol plus Vinomerix Optima® OPCs). If mitochondrial turnover via Urolithin A is your non-negotiable, Timeline remains the option for that specific mechanism, at a higher monthly cost than this protocol.
This is a 90-day protocol, not a 7-day hack. Cellular mechanisms operate on biological timelines. NAD+ pool stabilization and cumulative polyphenol antioxidant effects take weeks, not days. If you want acute nootropic effects by Thursday, this is not built for that. If you want systemic cellular improvement visible on your 90-day bloodwork panel, that is what this protocol is designed around.
You have the mechanism data, the cost comparison, the wearable outcomes, and the honest limitations. Here is your evaluation window.
See If This Protocol Fits Your StackThree options. No auto-ship tricks. Cancel or pause from your account dashboard without calling anyone.
Free US shipping on all orders. Delivery in 3-5 business days.
Cost per day: $2.17 on the quarterly plan. That is less than your daily serving of AG1.
255 mg of NMN reaches your cells more effectively. Net NAD+ accumulation with protection can exceed what 500mg achieves unprotected. The Jinfiniti NAD+ panel data from our users supports this.255 mg dose in CLADETM is designed to work within the full formula context, not as a standalone NMN protocol.Start the protocol. Track your HRV, resting heart rate, and sleep architecture on your Oura, Whoop, or Apple Watch. Get bloodwork at week 8 if you want the full picture. If your wearable data and subjective experience do not show measurable improvement in energy, recovery, or cognitive clarity within 90 days, you receive a full refund. No forms. No restocking fees. Free return shipping included.
You have spent months building a stack. You have the wearable data showing where it plateaued. The CD38 problem is published, documented, and unaddressed by every standalone NMN product on the market. The question is not whether NAD+ protection matters. The question is how long you want to keep filling a leaking bucket.
Start the NAD+ and Polyphenol Protocol. Free Shipping.Quarterly subscribers receive priority fulfillment on patented ingredients